Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Ugne Balaseviciute"'
Autor:
Vanessa Ortiz-Barahona, Marta Soler, Veronica Davalos, Carlos A. García-Prieto, Maxime Janin, Fernando Setien, Irene Fernández-Rebollo, Joan J. Bech-Serra, Carolina De La Torre, Sonia Guil, Alberto Villanueva, Pei-Hong Zhang, Li Yang, Marco Guarnacci, Ulrike Schumann, Thomas Preiss, Ugne Balaseviciute, Robert Montal, Josep M. Llovet, Manel Esteller
Publikováno v:
Molecular Cancer, Vol 22, Iss 1, Pp 1-15 (2023)
Abstract Background RNA modifications are important regulators of transcript activity and an increasingly emerging body of data suggests that the epitranscriptome and its associated enzymes are altered in human tumors. Methods Combining data mining a
Externí odkaz:
https://doaj.org/article/b94a70a8367746bebebcde0b3709b994
Autor:
Jordi Abril-Fornaguera, Laura Torrens, Carmen Andreu-Oller, Juan Carrillo-Reixach, Alex Rialdi, Ugne Balaseviciute, Roser Pinyol, Carla Montironi, Philipp K. Haber, Álvaro Del Río-Álvarez, Montserrat Domingo-Sàbat, Laura Royo, Nicholas K. Akers, Catherine E. Willoughby, Judit Peix, Miguel Torres-Martin, Marc Puigvehi, Stefano Cairo, Margaret Childs, Rudolf Maibach, Rita Alaggio, Piotr Czauderna, Bruce Morland, Bojan Losic, Vincenzo Mazzaferro, Ernesto Guccione, Daniela Sia, Carolina Armengol, Josep M. Llovet
Publikováno v:
Molecular Cancer Therapeutics. 22:485-498
Management of hepatoblastoma (HB), the most frequent pediatric liver cancer, is based on surgical resection and perioperative chemotherapy regimens. In this study, we aimed to identify actionable targets in HB and assess the efficacy of molecular the
Autor:
Josep M. Llovet, Carolina Armengol, Daniela Sia, Ernesto Guccione, Vincenzo Mazzaferro, Bojan Losic, Bruce Morland, Piotr Czauderna, Rita Alaggio, Rudolf Maibach, Margaret Childs, Stefano Cairo, Marc Puigvehi, Miguel Torres-Martin, Judit Peix, Catherine E. Willoughby, Nicholas K. Akers, Laura Royo, Montserrat Domingo-Sàbat, Álvaro Del Río-Álvarez, Philipp K. Haber, Carla Montironi, Roser Pinyol, Ugne Balaseviciute, Alex Rialdi, Juan Carrillo-Reixach, Carmen Andreu-Oller, Laura Torrens, Jordi Abril-Fornaguera
Management of hepatoblastoma (HB), the most frequent pediatric liver cancer, is based on surgical resection and perioperative chemotherapy regimens. In this study, we aimed to identify actionable targets in HB and assess the efficacy of molecular the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::390a621810712aa475236362b5db108a
https://doi.org/10.1158/1535-7163.c.6534814.v2
https://doi.org/10.1158/1535-7163.c.6534814.v2
Autor:
Josep M. Llovet, Carolina Armengol, Daniela Sia, Ernesto Guccione, Vincenzo Mazzaferro, Bojan Losic, Bruce Morland, Piotr Czauderna, Rita Alaggio, Rudolf Maibach, Margaret Childs, Stefano Cairo, Marc Puigvehi, Miguel Torres-Martin, Judit Peix, Catherine E. Willoughby, Nicholas K. Akers, Laura Royo, Montserrat Domingo-Sàbat, Álvaro Del Río-Álvarez, Philipp K. Haber, Carla Montironi, Roser Pinyol, Ugne Balaseviciute, Alex Rialdi, Juan Carrillo-Reixach, Carmen Andreu-Oller, Laura Torrens, Jordi Abril-Fornaguera
Supplementary Figures and Tables
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::567fb3a489dd0bab0c7470eb009aa094
https://doi.org/10.1158/1535-7163.22552095.v1
https://doi.org/10.1158/1535-7163.22552095.v1
Autor:
Josep M. Llovet, Roser Pinyol, Vincenzo Mazzaferro, Francesc Miró-Mur, Ugne Balaseviciute, Agavni Mesropian, Laura Torrens, Judit Peix, Jordi Abril-Fornaguera, Carla Montironi, Marta Piqué-Gili, Catherine E. Willoughby, Roger Esteban-Fabró
Supplementary Data from Cabozantinib Enhances Anti-PD1 Activity and Elicits a Neutrophil-Based Immune Response in Hepatocellular Carcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97ffaa4d727bb3739a23c5882a073c7a
https://doi.org/10.1158/1078-0432.22482771
https://doi.org/10.1158/1078-0432.22482771
Autor:
Josep M. Llovet, Roser Pinyol, Vincenzo Mazzaferro, Francesc Miró-Mur, Ugne Balaseviciute, Agavni Mesropian, Laura Torrens, Judit Peix, Jordi Abril-Fornaguera, Carla Montironi, Marta Piqué-Gili, Catherine E. Willoughby, Roger Esteban-Fabró
Supplementary Figure from Cabozantinib Enhances Anti-PD1 Activity and Elicits a Neutrophil-Based Immune Response in Hepatocellular Carcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06248adfc57ce9a522076ec74705eb04
https://doi.org/10.1158/1078-0432.22482765.v1
https://doi.org/10.1158/1078-0432.22482765.v1
Autor:
Josep M. Llovet, Roser Pinyol, Vincenzo Mazzaferro, Francesc Miró-Mur, Ugne Balaseviciute, Agavni Mesropian, Laura Torrens, Judit Peix, Jordi Abril-Fornaguera, Carla Montironi, Marta Piqué-Gili, Catherine E. Willoughby, Roger Esteban-Fabró
Purpose:Immune checkpoint inhibitors combined with antiangiogenic agents produce benefits in the treatment of advanced hepatocellular carcinoma (HCC). We investigated the efficacy and immunomodulatory activity of cabozantinib alone and combined with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f7929c70db7e53a23dad93d3b76a228
https://doi.org/10.1158/1078-0432.c.6530994.v1
https://doi.org/10.1158/1078-0432.c.6530994.v1
Autor:
Roger Esteban-Fabró, Catherine E. Willoughby, Marta Piqué-Gili, Carla Montironi, Jordi Abril-Fornaguera, Judit Peix, Laura Torrens, Agavni Mesropian, Ugne Balaseviciute, Francesc Miró-Mur, Vincenzo Mazzaferro, Roser Pinyol, Josep M. Llovet
Publikováno v:
Clin Cancer Res
Purpose: Immune checkpoint inhibitors combined with antiangiogenic agents produce benefits in the treatment of advanced hepatocellular carcinoma (HCC). We investigated the efficacy and immunomodulatory activity of cabozantinib alone and combined with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f5028d58a390b9bdd143c29777283b7
https://europepmc.org/articles/PMC9167725/
https://europepmc.org/articles/PMC9167725/
Autor:
Jordi Abril-Fornaguera, Laura Torrens, Juan Carrillo-Reixach, Alex Rialdi, Ugne Balaseviciute, Júlia Huguet-Pradell, Carla Montironi, Philipp Haber, Álvaro Del Río-Álvarez, Montserrat Domingo-Sàbat, Laura Royo, Nicholas Akers, Catherine E Willoughby, Judit Peix, Miguel Torres-Martin, Marc Puigvehi, Roser Pinyol, Stefano Cairo, Margaret Childs, Rudolf Maibach, Rita Alaggio, Piotr Czauderna, Bruce Morland, Bojan Losic, Vincenzo Mazzaferro, Ernesto Guccione, Daniela Sia, Carolina Armengol, Josep M Llovet
Publikováno v:
Clinical Cancer Research. 28:PO009-PO009
Background and Aims: Management of hepatoblastoma (HB), the most frequent pediatric liver cancer, is based on surgical resection and perioperative chemotherapy regimens, commonly cisplatin. Here, we aimed to identify actionable targets in HB and asse
Autor:
Jordi Abril-Fornaguera, Laura Torrens, Juan Carrillo-Reixach, Alexander Rialdi, Ugne Balaseviciute, Carla Montironi, Philipp Haber, Álvaro Del Río-Álvarez, Montserrat Domingo-Sàbat, Laura Royo, Nicholas Akers, Catherine E. Willoughby, Judit Peix, Miguel Torres-Martin, Marc Puigvehi, Roser Pinyol, Stefano Cairo, Margaret Childs, Rudolf Maibach, Rita Alaggio, Piotr Czauderna, Bruce Morland, Bojan Losic, Vincenzo Mazzaferro, Ernesto Guccione, Daniela Sia, Carolina Armengol, Josep M. Llovet
Publikováno v:
Cancer Research. 82:4005-4005
Background and Aims: Management of hepatoblastoma (HB), the most frequent pediatric liver cancer, is based on surgical resection and perioperative platin-based regimens, commonly cisplatin. Here, we aimed to identify actionable targets in HB and asse